Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston Sci's Innova OK'd By FDA To Treat Peripheral Artery Disease

This article was originally published in The Gray Sheet

Executive Summary

The vascular self-expanding stent system has been approved as an advanced treatment for patients with narrowing or blockages in their superficial femoral artery or proximal popliteal artery, which can lead to peripheral artery disease – a condition that affects 8 million Americans.

Advertisement

Related Content

Corrosion Testing For Nickel Stents Front And Center In FDA Final Update

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT034146

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel